Plasmablastic Lymphoma
Differential Diagnosis
- Immunoblastic diffuse large B cell lymphoma
- ALK positive diffuse large B cell lymphoma
- Primary effusion lymphoma
- Anaplastic (plasmablastic) plasmacytoma
- KSHV-associated germinotropic lymphoproliferative disorder
Plasmablastic Lymphoma | Immunoblastic DLBCL |
---|---|
Typically oral cavity mass in HIV+ patient | Wide variety of presentations, including HIV |
LCA negative or minimal + | LCA >90% |
CD20 minimal to negative, CD79a positive | Both CD20 and CD79a >90% |
Ki67 >95% | Ki67 moderately high, variable |
EBV in situ 50% | EBV in situ rare in de novo cases; frequent in immunodeficiency cases |
CD138 positive | CD138 negative |
Plasmablastic Lymphoma | Primary Effusion Lymphoma |
---|---|
Not body cavity based (frequently oral cavity) | Involves body cavity |
CD45RB weak to negative | CD45RB positive |
HHV8 only if associated with Castleman disease | HHV8 positive |
Both entities share cytologic features and may also be CD20 and CD45RB negative or minimally reactive
Plasmablastic Lymphoma | ALK Positive DLBCL |
---|---|
Typically oral cavity mass in HIV+ patient | Wide variety of presentations |
ALK negative | ALK positive |
CD79a positive | CD79a negative |
CD138 positive | CD138 negative |
Plasmablastic Lymphoma | Anaplastic (Plasmablastic) Plasmacytoma/Myeloma |
---|---|
Plasmablastic morphology | Subset plasmablastic |
Often HIV+ or otherwise immunosuppressed | Usually not immunosuppressed |
Often in oral cavity or mucosal areas of head | Extraosseous sites overlap |
~60% EBV+ | usually EBV negative |
Plasmablastic Lymphoma | KSHV-associated Germinotropic Lymphoproliferative Disorder |
---|---|
Typically oral cavity | Localized lymphadenopathy |
Immunosupressed patient | Immunocompetent patient |
Sheets of plasmablasts | Plasmablasts involve germinal centers |
Some cases associated with multicentric Castleman disease (MCD) | No Castleman features in follicles |
EBV 50% positive | EBV positve |